Literature DB >> 15164243

Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer.

Thomas D Cecil1, Rosemary Sexton, Brendan J Moran, Richard J Heald.   

Abstract

PURPOSE: Most series report lymph node involvement as the main predictor for local recurrence. The principal lymphatic drainage of the rectum is to nodes in the mesorectum and then nodes along the superior rectal and inferior mesenteric arteries. If total mesorectal excision provides adequate block dissection of the lymphatics of the rectum, good local control with low rates of local recurrence should be achieved even in node-positive disease.
METHODS: Prospective data on all rectal cancers have been collected since 1978; 170 patients with Dukes C rectal cancer have undergone anterior resection and total mesorectal excision. We did not perform any internal iliac node dissections. Follow-up data were analyzed for local recurrence and distant recurrence.
RESULTS: The local recurrence rate was 2 percent for Dukes A cases, 4 percent for Dukes B, and 7.5 percent for Dukes C ( P = 0.0127). The systemic recurrence rate was 8 percent for Dukes A, 18 percent for Dukes B, and 37 percent for Dukes C ( P = 0.0001).
CONCLUSIONS: If surgical priority is given to the difficult task of excision of the whole mesorectum, anterior resection with total mesorectal excision in node-positive rectal cancer, local recurrence rates of < 10 percent can be achieved.

Entities:  

Mesh:

Year:  2004        PMID: 15164243     DOI: 10.1007/s10350-004-0086-6

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  44 in total

Review 1.  Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy.

Authors:  Reetesh K Pai; Rish K Pai
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

Review 2.  Anatomy of the lateral ligaments of the rectum: a controversial point of view.

Authors:  Guo-Jun Wang; Chun-Fang Gao; Dong Wei; Cun Wang; Wen-Jian Meng
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

3.  Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging.

Authors:  Chan Kyo Kim; Seung Hoon Kim; Ho Kyung Chun; Woo-Yong Lee; Seong-Hyeon Yun; Sang-Yong Song; Dongil Choi; Hyo Keun Lim; Min Ju Kim; Jongmee Lee; Soon Jin Lee
Journal:  Eur Radiol       Date:  2006-01-17       Impact factor: 5.315

Review 4.  The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment.

Authors:  Jeremy R Parfitt; David K Driman
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

5.  Laparoscopy for colon and rectal cancer.

Authors:  Govind Nandakumar; James W Fleshman
Journal:  Clin Colon Rectal Surg       Date:  2010-02

6.  Transanal total mesorectal excision (TaTME): single-centre early experience in a selected population.

Authors:  Michele De Rosa; Fabio Rondelli; Marcello Boni; Fabio Ermili; Walter Bugiantella; Lorenzo Mariani; Graziano Ceccarelli; Antonio Giuliani
Journal:  Updates Surg       Date:  2018-11-08

7.  Lymph node metastasis of carcinomas of transverse colon including flexures. Consideration of the extramesocolic lymph node stations.

Authors:  Aristotelis Perrakis; Klaus Weber; Susanne Merkel; Klaus Matzel; Abbas Agaimy; Carol Gebbert; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2014-07-25       Impact factor: 2.571

8.  Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.

Authors:  Paul Hermanek; Susanne Merkel; Rainer Fietkau; Claus Rödel; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2009-12-10       Impact factor: 2.571

9.  Adjuvant therapy for rectal cancer.

Authors:  Smitha S Krishnamurthi; Yuji Seo; Timothy J Kinsella
Journal:  Clin Colon Rectal Surg       Date:  2007-08

10.  Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer.

Authors: 
Journal:  Curr Oncol       Date:  2009-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.